Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024
Lifecore Biomedical (NASDAQ: LFCR) has announced plans to host a virtual investor day on Thursday, November 21, 2024, from 8:00 to 9:30 a.m. Eastern Time.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Lifecore Biomedical (NASDAQ: LFCR) has announced plans to host a virtual investor day on Thursday, November 21, 2024, from 8:00 to 9:30 a.m. Eastern Time. The event, scheduled before market opening, will feature presentations from the company's senior management team discussing business strategies and future growth plans.
Interested participants can access the live webcast or archived recording through the Events & Presentations section on Lifecore's investor webpage at ir.lifecore.com/events-presentations. The company, operating as a fully integrated contract development and manufacturing organization (CDMO), aims to provide comprehensive insights into its operations and future direction.
Details
News Market Reaction – LFCR
The recorded move for LFCR in the trading session of this news was -0.31%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CHASKA, Minn., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will host a virtual investor day on Thursday, November 21, 2024, prior to market open. The event will take place from 8:00 – 9:30 a.m. Eastern Time and be available via webcast. During the event, members of Lifecore’s senior management team will discuss the company’s business and strategy for growth in the future, among other topics.
To listen to the live webcast, or access the archived webcast, please visit the Events & Presentations section of Lifecore’s investor web page at: https://ir.lifecore.com/events-presentations.
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.